Summary of Study ST001242
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR000830. The data can be accessed directly via it's Project DOI: 10.21228/M8D68Q This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.
Study ID | ST001242 |
Study Title | Global Metabolic Analysis Trisomy 21 - Cohort 3, CSF |
Study Summary | global metabolic analysis of CSF from individuals with and without trisomy 21. |
Institute | University of Colorado Denver |
Last Name | Culp-Hill |
First Name | Rachel |
Address | 12801 E 17th Ave L18-9403D, Aurora, Colorado, 80045, USA |
rachel.hill@cuanschutz.edu | |
Phone | 303-724-5798 |
Submit Date | 2019-08-13 |
Raw Data Available | Yes |
Raw Data File Type(s) | raw(Thermo) |
Analysis Type Detail | LC-MS |
Release Date | 2019-08-21 |
Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Project:
Project ID: | PR000830 |
Project DOI: | doi: 10.21228/M8D68Q |
Project Title: | Trisomy 21 activates the kynurenine pathway via increased dosage of interferon receptors |
Project Summary: | Trisomy 21 (T21) causes Down syndrome (DS), affecting immune and neurological function by unknown mechanisms. We report here a large metabolomics study of plasma and cerebrospinal fluid showing that people with DS produce elevated levels of kynurenine and quinolinic acid, two tryptophan catabolites with potent immunosuppressive and neurotoxic properties, respectively. We demonstrate that immune cells of people with DS overexpress IDO1, the rate-limiting enzyme in the kynurenine pathway (KP) and a known interferon (IFN)-stimulated gene. Furthermore, we show positive correlations among levels of IFN-inducible cytokines and KP dysregulation. Using metabolic tracing assays, we determine that IFN stimulation causes IDO1 overexpression and kynurenine overproduction in cells with T21, dependent on overexpression of IFN receptors encoded on chromosome 21. Finally, we show a mouse model of DS carrying triplication of the IFN receptors exhibits KP dysregulation. Altogether, these results reveal a mechanism by which T21 could drive immunosuppression and neurotoxicity in DS. |
Institute: | University of Colorado Denver |
Laboratory: | Linda Crnic Institute, Costello Lab, D'Alessandro Lab |
Last Name: | Culp-Hill |
First Name: | Rachel |
Address: | 12801 E 17th Ave L18-9403D, Aurora, Colorado, 80045, USA |
Email: | rachel.hill@cuanschutz.edu |
Phone: | 303-724-5798 |
Subject:
Subject ID: | SU001310 |
Subject Type: | Human |
Subject Species: | Homo sapiens |
Taxonomy ID: | 9606 |
Age Or Age Range: | 0.5 - 76.5 |
Gender: | Male and female |
Factors:
Subject type: Human; Subject species: Homo sapiens (Factor headings shown in green)
mb_sample_id | local_sample_id | Cohort |
---|---|---|
SA090368 | SPIN_5neg_D21_68-L17-131 | D21 |
SA090369 | SPIN_5neg_D21_69-L17-170 | D21 |
SA090370 | SPIN_5neg_D21_67-L17-125 | D21 |
SA090371 | SPIN_5neg_D21_66-L17-090 | D21 |
SA090372 | SPIN_5neg_D21_65-L17-032 | D21 |
SA090373 | SPIN_5neg_D21_70-L17-207 | D21 |
SA090374 | SPIN_5neg_D21_71-L17-210 | D21 |
SA090375 | SPIN_5neg_D21_75-L17-276 | D21 |
SA090376 | SPIN_5neg_D21_74-L17-274 | D21 |
SA090377 | SPIN_5neg_D21_73-L17-246 | D21 |
SA090378 | SPIN_5neg_D21_72-L17-235 | D21 |
SA090379 | SPIN_5neg_D21_64-L16-208 | D21 |
SA090380 | SPIN_5neg_D21_62-L16-153 | D21 |
SA090381 | SPIN_5neg_D21_55-L16-048 | D21 |
SA090382 | SPIN_5neg_D21_56-L16-056 | D21 |
SA090383 | SPIN_5neg_D21_54-L16-033 | D21 |
SA090384 | SPIN_5neg_D21_53-L16-009 | D21 |
SA090385 | SPIN_5neg_D21_52-L15-195 | D21 |
SA090386 | SPIN_5neg_D21_57-L16-086 | D21 |
SA090387 | SPIN_5neg_D21_58-L16-087 | D21 |
SA090388 | SPIN_5neg_D21_76-L17-292 | D21 |
SA090389 | SPIN_5neg_D21_61-L16-146 | D21 |
SA090390 | SPIN_5neg_D21_60-L16-145 | D21 |
SA090391 | SPIN_5neg_D21_59-L16-107 | D21 |
SA090392 | SPIN_5neg_D21_63-L16-202 | D21 |
SA090393 | SPIN_5neg_D21_77-L18-020 | D21 |
SA090394 | SPIN_5neg_D21_93-L19-007 | D21 |
SA090395 | SPIN_5neg_D21_94-L19-014 | D21 |
SA090396 | SPIN_5neg_D21_92-L19-006 | D21 |
SA090397 | SPIN_5neg_D21_91-L18-342 | D21 |
SA090398 | SPIN_5neg_D21_90-L18-314 | D21 |
SA090399 | SPIN_5neg_D21_95-L19-015 | D21 |
SA090400 | SPIN_5neg_D21_96-L19-016 | D21 |
SA090401 | SPIN_5neg_D21_100-L19-114 | D21 |
SA090402 | SPIN_5neg_D21_99-L19-080 | D21 |
SA090403 | SPIN_5neg_D21_98-L19-065 | D21 |
SA090404 | SPIN_5neg_D21_97-L19-032 | D21 |
SA090405 | SPIN_5neg_D21_89-L18-303 | D21 |
SA090406 | SPIN_5neg_D21_88-L18-302 | D21 |
SA090407 | SPIN_5neg_D21_81-L18-098 | D21 |
SA090408 | SPIN_5neg_D21_80-L18-044 | D21 |
SA090409 | SPIN_5neg_D21_79-L18-028 | D21 |
SA090410 | SPIN_5neg_D21_78-L18-021 | D21 |
SA090411 | SPIN_5neg_D21_82-L18-130 | D21 |
SA090412 | SPIN_5neg_D21_83-L18-162 | D21 |
SA090413 | SPIN_5neg_D21_87-L18-238 | D21 |
SA090414 | SPIN_5neg_D21_86-L18-205 | D21 |
SA090415 | SPIN_5neg_D21_85-L18-197 | D21 |
SA090416 | SPIN_5neg_D21_84-L18-170 | D21 |
SA090417 | SPIN_5pos_D21_51-L15-181 | D21 |
SA090418 | SPIN_5neg_D21_51-L15-181 | D21 |
SA090419 | SPIN_5pos_D21_84-L18-170 | D21 |
SA090420 | SPIN_5pos_D21_83-L18-162 | D21 |
SA090421 | SPIN_5pos_D21_85-L18-197 | D21 |
SA090422 | SPIN_5pos_D21_86-L18-205 | D21 |
SA090423 | SPIN_5pos_D21_87-L18-238 | D21 |
SA090424 | SPIN_5pos_D21_82-L18-130 | D21 |
SA090425 | SPIN_5pos_D21_81-L18-098 | D21 |
SA090426 | SPIN_5pos_D21_77-L18-020 | D21 |
SA090427 | SPIN_5pos_D21_78-L18-021 | D21 |
SA090428 | SPIN_5pos_D21_79-L18-028 | D21 |
SA090429 | SPIN_5pos_D21_80-L18-044 | D21 |
SA090430 | SPIN_5pos_D21_88-L18-302 | D21 |
SA090431 | SPIN_5pos_D21_89-L18-303 | D21 |
SA090432 | SPIN_5pos_D21_96-L19-016 | D21 |
SA090433 | SPIN_5pos_D21_97-L19-032 | D21 |
SA090434 | SPIN_5pos_D21_98-L19-065 | D21 |
SA090435 | SPIN_5pos_D21_99-L19-080 | D21 |
SA090436 | SPIN_5pos_D21_95-L19-015 | D21 |
SA090437 | SPIN_5pos_D21_94-L19-014 | D21 |
SA090438 | SPIN_5pos_D21_90-L18-314 | D21 |
SA090439 | SPIN_5pos_D21_91-L18-342 | D21 |
SA090440 | SPIN_5pos_D21_92-L19-006 | D21 |
SA090441 | SPIN_5pos_D21_93-L19-007 | D21 |
SA090442 | SPIN_5pos_D21_75-L17-276 | D21 |
SA090443 | SPIN_5pos_D21_74-L17-274 | D21 |
SA090444 | SPIN_5pos_D21_58-L16-087 | D21 |
SA090445 | SPIN_5pos_D21_59-L16-107 | D21 |
SA090446 | SPIN_5pos_D21_60-L16-145 | D21 |
SA090447 | SPIN_5pos_D21_61-L16-146 | D21 |
SA090448 | SPIN_5pos_D21_57-L16-086 | D21 |
SA090449 | SPIN_5pos_D21_56-L16-056 | D21 |
SA090450 | SPIN_5pos_D21_52-L15-195 | D21 |
SA090451 | SPIN_5pos_D21_53-L16-009 | D21 |
SA090452 | SPIN_5pos_D21_54-L16-033 | D21 |
SA090453 | SPIN_5pos_D21_55-L16-048 | D21 |
SA090454 | SPIN_5pos_D21_62-L16-153 | D21 |
SA090455 | SPIN_5pos_D21_63-L16-202 | D21 |
SA090456 | SPIN_5pos_D21_70-L17-207 | D21 |
SA090457 | SPIN_5pos_D21_71-L17-210 | D21 |
SA090458 | SPIN_5pos_D21_72-L17-235 | D21 |
SA090459 | SPIN_5pos_D21_73-L17-246 | D21 |
SA090460 | SPIN_5pos_D21_69-L17-170 | D21 |
SA090461 | SPIN_5pos_D21_68-L17-131 | D21 |
SA090462 | SPIN_5pos_D21_64-L16-208 | D21 |
SA090463 | SPIN_5pos_D21_65-L17-032 | D21 |
SA090464 | SPIN_5pos_D21_66-L17-090 | D21 |
SA090465 | SPIN_5pos_D21_67-L17-125 | D21 |
SA090466 | SPIN_5pos_D21_100-L19-114 | D21 |
SA090467 | SPIN_5pos_D21_76-L17-292 | D21 |
Collection:
Collection ID: | CO001304 |
Collection Summary: | All human subjects in this study were consented according to Colorado Multiple Institutional Review Board (COMIRB)-approved protocols. Written informed consent was obtained from parents or guardians of participants under the age of 18, and assent was obtained from participants over the age of 7 who were cognitively able to assent. Deidentified plasma samples for Cohort 1 were obtained from the Translational Nexus Clinical Data Registry and Biobank (University of Colorado Anschutz Medical Campus, COMIRB 08-1276). Additional plasma and WBC samples were obtained through the Crnic’s Institute Human Trisome Project (University of Colorado Anschutz Medical Campus, COMIRB 15-2170, www.trisome.org). Plasma was collected in Vacutainer tubes (EDTA–purple capped or Lithium heparin–light green capped) and stored at -80°C. Participant medical history was collected by the respective biobanks. |
Sample Type: | Cerebrospinal fluid |
Treatment:
Treatment ID: | TR001325 |
Treatment Summary: | N/A |
Sample Preparation:
Sampleprep ID: | SP001318 |
Sampleprep Summary: | For CSF analyses, a volume of 20μL of was extracted in 180μL of ice-cold methanol:acetonitrile:water (5:3:2). Subsequently, these solutions were vortexed for 30 minutes at 4°C. Insoluble proteins were pelleted by centrifugation (10 minutes at 4°C and 12,000 g) and supernatants were collected and stored at -80°C until analysis. For quantitative analysis of kynurenine pathway (KP) metabolites, supernatants were spun in a Speedvac until dry and resuspended in 0.1% formic acid in water as previously described (PMID: 30213797, 30143553). |
Combined analysis:
Analysis ID | AN002063 | AN002064 |
---|---|---|
Analysis type | MS | MS |
Chromatography type | Reversed phase | Reversed phase |
Chromatography system | Thermo Vanquish | Thermo Vanquish |
Column | Phenomenex Kinetex C18 (150 x 2.1mm,2.6um) | Phenomenex Kinetex C18 (150 x 2.1mm,2.6um) |
MS Type | ESI | ESI |
MS instrument type | Orbitrap | Orbitrap |
MS instrument name | Thermo Q Exactive Orbitrap | Thermo Q Exactive Orbitrap |
Ion Mode | POSITIVE | NEGATIVE |
Units | relative abundance | relative abundance |
Chromatography:
Chromatography ID: | CH001501 |
Chromatography Summary: | UHPLC-MS metabolomics analyses were performed using a Vanquish UHPLC system coupled online to a Q Exactive mass spectrometer (Thermo Fisher, Bremen, Germany). 20uL of supernatant was injected for plasma and CSF samples, and 10uL of supernatant was injected for cell samples. Samples were resolved over a Kinetex C18 column (2.1x150 mm, 1.7μm; Phenomenex, Torrance, CA, USA) at 45°C using a 5-minute gradient at 450μL/minute from 5-95% B (A: water/0.1% formic acid; B: acetonitrile/0.1% formic acid) for positive mode. To monitor possible technical variability, aliquots of each of the individual samples were combined to make technical replicates, which were run after every 15 samples. Additionally, in each experiment, several lysis solution aliquots were run as blanks for artifact identification. |
Methods Filename: | 5MMpos_method.pdf |
Instrument Name: | Thermo Vanquish |
Column Name: | Phenomenex Kinetex C18 (150 x 2.1mm,2.6um) |
Column Temperature: | 45 |
Flow Gradient: | 5-95% B |
Flow Rate: | 450uL/min |
Solvent A: | 100% water; 0.1% formic acid |
Solvent B: | 100% acetonitrile; 0.1% formic acid |
Chromatography Type: | Reversed phase |
Chromatography ID: | CH001502 |
Chromatography Summary: | UHPLC-MS metabolomics analyses were performed using a Vanquish UHPLC system coupled online to a Q Exactive mass spectrometer (Thermo Fisher, Bremen, Germany). 20uL of supernatant was injected for each sample. Samples were resolved over a Kinetex C18 column (2.1x150 mm, 1.7μm; Phenomenex, Torrance, CA, USA) at 45°C using a 5-minute gradient at 450μL/minute from 0-100% B (A: 95% water/5% acetonitrile, 1mM NH4OAc; B: 95% acetonitrile/5% water, 1mM NH4OAc) for negative mode. To monitor possible technical variability, aliquots of each of the individual samples were combined to make technical replicates, which were run after every 15 samples. Additionally, in each experiment, several lysis solution aliquots were run as blanks for artifact identification. |
Methods Filename: | 5MMneg_method.pdf |
Instrument Name: | Thermo Vanquish |
Column Name: | Phenomenex Kinetex C18 (150 x 2.1mm,2.6um) |
Column Temperature: | 45 |
Flow Gradient: | 0-100% B |
Flow Rate: | 450uL/min |
Solvent A: | 95% water/5% acetonitrile; 1 mM ammonium acetate |
Solvent B: | 95% acetonitrile/5% water; 1 mM ammonium acetate |
Chromatography Type: | Reversed phase |
MS:
MS ID: | MS001914 |
Analysis ID: | AN002063 |
Instrument Name: | Thermo Q Exactive Orbitrap |
Instrument Type: | Orbitrap |
MS Type: | ESI |
MS Comments: | The Q Exactive mass spectrometer (Thermo Fisher Scientific, San Jose, CA, USA) was operated in positive ion mode using electrospray ionization, scanning in Full MS mode (1μscan) from 65 to 975 m/z at 70,000 resolution, with 4 kV spray voltage, 45 sheath gas, 15 auxiliary gas. MS analysis and data elaboration were performed as described74,75. Calibration was performed prior to analysis using the PierceTM Positive Ion Calibration Solution (Thermo Fisher Scientific). |
Ion Mode: | POSITIVE |
MS ID: | MS001915 |
Analysis ID: | AN002064 |
Instrument Name: | Thermo Q Exactive Orbitrap |
Instrument Type: | Orbitrap |
MS Type: | ESI |
MS Comments: | The Q Exactive mass spectrometer (Thermo Fisher Scientific, San Jose, CA, USA) was operated in negative ion mode using electrospray ionization, scanning in Full MS mode (1μscan) from 65 to 975 m/z at 70,000 resolution, with 4 kV spray voltage, 45 sheath gas, 15 auxiliary gas. MS analysis and data elaboration were performed as described74,75. Calibration was performed prior to analysis using the PierceTM Negative Ion Calibration Solution (Thermo Fisher Scientific). |
Ion Mode: | NEGATIVE |